Christoph Schmid

Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With <i>FLT3</i>–Internal Tandem Duplication Mutation (SORMAIN)

Andreas Burchert, Gesine Bug, Lea Fritz et al. · Journal of Clinical Oncology · 2020 · 551 citations · Full text

Medicine, Hematology, Oncology +15

Donor Lymphocyte Infusion in the Treatment of First Hematological Relapse After Allogeneic Stem-Cell Transplantation in Adults With Acute Myeloid Leukemia: A Retrospective Risk Factors Analysis and Comparison With Other Strategies by the EBMT Acute Leukemia Working Party

Christoph Schmid, Myriam Labopin, Arnon Nagler et al. · Journal of Clinical Oncology · 2007 · 516 citations · Full text

Medicine, Hematology, Immunology +17

Sequential Regimen of Chemotherapy, Reduced-Intensity Conditioning for Allogeneic Stem-Cell Transplantation, and Prophylactic Donor Lymphocyte Transfusion in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome

Christoph Schmid, Michael Schleuning, Georg Ledderose et al. · Journal of Clinical Oncology · 2005 · 419 citations

Medicine, Oncology, Cell Therapy +15

Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation

Christoph Schmid · Blood · 2006 · 397 citations · Full text

Medicine, Hematology, Oncology +17

Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation

Christoph Schmid, Myriam Labopin, Arnon Nagler et al. · Blood · 2011 · 311 citations · Full text

Medicine, Hematology, Oncology +16